US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 26.330
  • +0.830+3.25%
Close Apr 26 16:00 ET
  • 26.330
  • 0.0000.00%
Post 16:20 ET
1.22BMarket Cap29.58P/E (TTM)

About Pacira BioSciences Company

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Company Profile

SymbolPCRX
Company NamePacira BioSciences
Listing DateFeb 3, 2011
Issue Price7.00
Founded2006
CEOMr. Frank D. Lee
MarketNASDAQ
Employees713
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5401 West Kennedy Boulevard,Suite 890
CityTampa
ProvinceFlorida
CountryUnited States of America
Zip Code33609
Phone1-813-553-6680
Websitehttp://www.pacira.com

Company Executives

  • Name
  • Position
  • Salary
  • Frank D. Lee
  • Director and Chief Executive Officer
  • --
  • Charles A. Reinhart, C.P.A.,M.B.A.
  • Chief Financial Officer
  • 1.43M
  • Daryl Gaugler
  • Chief Operating Officer
  • 1.53M
  • Kristen Marie Williams
  • Chief Administrative Officer and Secretary
  • 1.60M
  • Jonathan Slonin
  • Chief Medical Officer
  • 1.59M
  • Lauren Riker
  • Senior Vice President, Finance and Principal Accounting Officer
  • --
  • Paul J. Hastings
  • Chairman of the Board
  • 390.51K
  • Governor Christopher J. Christie
  • Independent Director
  • 325.01K
  • Dr. Mark A. Kronenfeld, M.D.
  • Independent Director
  • 373.01K
  • Dr. Gary W. Pace,PhD
  • Independent Director
  • 343.01K
  • Dr. Andreas Wicki, PhD
  • Independent Director
  • --
  • Michael J. Yang
  • Independent Director
  • 427.16K
  • Laura A. Brege
  • Independent Director
  • 364.01K
  • Alethia Young
  • Independent Director
  • 427.86K
  • Dr. Mark I. Froin, M.D.
  • Independent Director
  • 349.01K
  • Abraham Ceesay
  • Independent Director
  • 427.16K
  • Dr. Marcelo Bigal, M.D.,PhD
  • Independent Director
  • 426.45K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg